Related Experiment Video
Updated: Jul 30, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
[Neurological complications associated with immune checkpoint inhibitors]
Magne Solberg Nes1, Åsmund Flobak2, Christian Vedeler3
1Nevrologisk avdeling, St. Olavs hospital.
None:
Immune-mediated toxicity from the use of immune checkpoint inhibitors is very common and can affect both the peripheral and central nervous systems. Given the potentially serious side effects, clinicians must maintain a high level of vigilance. The aim of this clinical review is to describe neurotoxic complications associated with the use of immune checkpoint inhibitors in cancer treatment.
More Related Videos
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Cryptococcal Meningitis
Complications of Diabetes Mellitus
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Cytotoxic Edema: Pathophysiology